The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH‐wildtype primary glioblastoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Histopathology

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/his.13142PMID 27926792
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells

  2016cited by this paper
• The diagnostic and prognostic value of SALL4 in hepatoblastoma

  2016cited by this paper
• Emx2 as a novel tool to suppress glioblastoma

  2016cited by this paper
• Statistical considerations on prognostic models for glioma.

  2016cited by this paper
• Fenofibrate induces G0/G1 phase arrest by modulating the PPARα/FoxO1/p27kip pathway in human glioblastoma cells

  2015cited by this paper
• Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR

  2015cited by this paper
• Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.

  2015cited by this paper
• Phosphatidic Acid (PA) can Displace PPARα/LXRα Binding to The EGFR Promoter Causing its Transrepression in Luminal Cancer Cells

  2015cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells

  2015cited by this paper
• Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer

  2015cited by this paper
• The epidemiology of glioma in adults: a "state of the science" review.

  2015cited by this paper
• Reductions in kinesin expression are associated with nitric oxide-induced axonal damage

  2015cited by this paper
• EGFR and EGFRvIII analysis in glioblastoma as therapeutic biomarkers

  2015cited by this paper
• PPARα activation can help prevent and treat non-small cell lung cancer.

  2014cited by this paper
• Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells

  2014cited by this paper
• Biological Rationale for the Use of PPARγ Agonists in Glioblastoma

  2014cited by this paper
• Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

  2014cited by this paper
• RETRACTED ARTICLE: Methylation and Expression Patterns of Tropomyosin-Related Kinase Genes in Different Grades of Glioma

  2014cited by this paper
• Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment

  2014cited by this paper
• Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway

  2014cited by this paper
• Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death

  2014cited by this paper
• The epidemiology of glioma in adults: a "state of the science" review.

  2014cited by this paper
• Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

  2013cited by this paper
• FFPE tissue as a feasible source for gene expression analysis--a comparison of three reference genes and one tumor marker.

  2013cited by this paper
• Incorporation of Prognostic and Predictive Factors Into Glioma Clinical Trials

  2013cited by this paper
• Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition

  2013cited by this paper
• IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker

  2013cited by this paper
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• Targeting 3-phosphoinositide-dependent protein kinase 1 by N-acetyl-cysteine through activation of peroxisome proliferators activated receptor alpha in human lung cancer cells, the role of p53 and p65

  2013cited by this paper
• Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia.

  2013cited by this paper
• Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis

  2013cited by this paper
• The Definition of Primary and Secondary Glioblastoma

  2012cited by this paper
• Paradoxical Relationship Between the Degree of EGFR Amplification and Outcome in Glioblastomas

  2012cited by this paper
• Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro

  2012cited by this paper
• A restricted cell population propagates glioblastoma growth after chemotherapy

  2012cited by this paper
• A restricted cell population propagates glioblastoma growth following chemotherapy

  2012cited by this paper
• Hypoxia induces peroxisome proliferator‐activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells

  2011cited by this paper
• NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.

  2011cited by this paper
• Immunohistochemical Analyses of NPAS3 Expression in the Developing Human Fetal Brain

  2011cited by this paper
• Role of aquaporin-4 in the regulation of migration and invasion of human glioma cells.

  2011cited by this paper
• ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro

  2010cited by this paper
• Lipid Metabolism Impairment in Human Gliomas: Expression of Peroxisomal Proteins in Human Gliomas at Different Grades of Malignancy

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas

  2010cited by this paper
• Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

  2010cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• IDH1 and IDH2 mutations in gliomas.

  2009cited by this paper
• Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.

  2009cited by this paper
• IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas

  2009cited by this paper
• Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

  2009cited by this paper
• Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.

  2009cited by this paper
• Ten-year all-cause mortality in presumably healthy subjects on lipid-lowering drugs (from the Prospective Epidemiological Study of Myocardial Infarction [PRIME] prospective cohort).

  2009cited by this paper
• Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research

  2009cited by this paper
• Analysis of the IDH1 codon 132 mutation in brain tumors

  2008cited by this paper
• PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition

  2008cited by this paper
• Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.

  2007cited by this paper
• Peroxisome proliferator-activated receptor α and γ ligands inhibit the growth of human ovarian cancer

  2007cited by this paper
• Effects of Emx2 inactivation on the gene expression profile of neural precursors

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

  2006cited by this paper
• A review of statistical outlier methods

  2006cited by this paper
• Epidemiology and etiology of gliomas

  2005cited by this paper
• Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

  2003cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

  2000cited by this paper

• The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness

  2025cites this paper
• Cut the fat: targeting cholesterol and lipid metabolism in glioblastoma

  2025cites this paper
• Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment

  2025cites this paper
• Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects

  2025cites this paper
• Lipid metabolism: the potential therapeutic targets in glioblastoma

  2025cites this paper
• Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets

  2025cites this paper
• mRNA markers for survival prediction in glioblastoma multiforme patients: a systematic review with bioinformatic analyses

  2024cites this paper
• Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case–control studies using the UK Clinical Practice Research Datalink (CPRD)

  2024cites this paper
• Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma

  2023cites this paper
• Potential Therapeutic Effects of PPAR Ligands in Glioblastoma

  2022cites this paper
• Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice

  2022cites this paper
• Paracelsus Paradox and Drug Repurposing for Cancer

  2021cites this paper
• Inhibition of the Lipid Droplet–Peroxisome Proliferator-Activated Receptor α Axis Suppresses Cancer Stem Cell Properties

  2021cites this paper
• Glioma Stem-Like Cells and Metabolism: Potential for Novel Therapeutic Strategies

  2021cites this paper
• Role of treatments for diabetes and hyperlipidaemia in risk and mortality of primary and secondary brain tumours

  2020cites this paper
• CMAR_A_252873 2937..2945

  2020cites this paper
• Expression Pattern and Prognostic Utility of PME-1 in Patients with Hepatocellular Carcinoma

  2020cites this paper
• OSgbm: An Online Consensus Survival Analysis Web Server for Glioblastoma

  2020influential citation
• CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma

  2019cites this paper
• PPARα agonist alleviates tumor growth and chemo-resistance associated with the inhibition of glucose metabolic pathway.

  2019cites this paper
• Overexpression and clinical relevance of the RNA helicase DHX15 in hepatocellular carcinoma.

  2019cites this paper
• Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks

  2019cites this paper
• Deconvolution and network analysis of IDH-mutant lower grade glioma predict recurrence and indicate therapeutic targets.

  2019cites this paper
• Ubiquitin-specific protease 11 serves as a marker of poor prognosis and promotes metastasis in hepatocellular carcinoma

  2018cites this paper
• shRNA‐mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth

  2018cites this paper
• Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays

  2018cites this paper